Skip to main content

Executive summary

A brief overview of the NHS’s overall vulnerability to fraud, bribery and corruption.

  • For 2025 - 26, the amount of NHS funding vulnerable to loss through fraud, bribery, and corruption in England is estimated to be £1.301bn, a reduction of £45.06m compared with the SIA 2025.
  • This equates to 0.66% of the Total Managed Expenditure for the NHS for 2025 - 2026 of £198.095bna , a decrease compared to the previous year.
  • The NHSCFA received 8,048 reports in 2025 - 26, with 7,645 aligning to the main thematic areas, showing an increase of almost 19% when compared with 2024 - 2025.
  • The areas which received the highest number of reports were NHS staff fraud, patient exemption fraud, procurement and commissioning fraud, and fraudulent access to NHS care from overseas visitors, accounting for approximately 84% of reporting.
  • The five highest financial vulnerabilities are procurement and commissioning fraud (£442.7m), patient exemption fraud (£268.76m), pharmaceutical contractor fraud (£138.49m), GP contractor fraud (£114.41m) and fraudulent access to NHS care from overseas visitors (£96.5m).
  • Regional reporting remains highest in London, the Midlands and the North East and Yorkshire, indicating a continued concentration of reporting in areas with high population density.
  • The NHSCFA’s approach towards being an intelligence-led organisation has been improved over the last few years, as we now analyse fraud at local, regional and national level, both strategically and tactically, allowing for the allocation of resourcing based on demand, including for emerging and prevalent trends.
  • Overall, the assessment shows a reduction in estimated financial vulnerability alongside rising reporting volumes, suggesting a continued need for focused prevention and enforcement activity.
Financial vulnerability estimates by Thematic area, 2025 to 2026 compared with 2024 to 2025
Thematic area 2025–2026 financial vulnerability estimate 2024–2025 financial vulnerability estimateb Difference (£m) 2025–2026 reports received by the NHSCFA
Procurement and commissioning fraud £442.7m £392.5m £50.2m 665
Patient exemption fraud £268.76m £230.2m £38.56m 1820
Pharmaceutical contractor fraud £138.49m £135.2m £3.31m 297
GP contractor fraud £114.41m £116.7m -£2.27m 222
Fraudulent access to NHS care from overseas visitors £96.5m £98.1m -£1.58m 544
Optical contractor fraud £91.22m £90.7m £0.57m 45
Data manipulation fraud £57.36m £189.1m -£131.69m 14
Dental contractor fraud £56.96m £57.6m £-0.62m 176
NHS staff fraud £28.17m £27.8m £0.41m 3753
NHS bursary fraud £3.69m £3.8m -£0.12m 23
NHS pension fraud £2.09m £4.1m -£2.01m 74
Reciprocal healthcare fraud £0.99m £0.8m £0.17m 12
Total £1.301bn £1.346bn -£45.06m 7645c

  1. Total NHS revenue department expenditure limit (RDEL) as per financial directions
  2. Financial vulnerability estimates run a year in arrears to reporting data; therefore, this assessment will include 2024 – 2025 financial data and 2025 – 2026 reporting data.
  3. There are an additional 403 reports which did not align to a thematic area; therefore, the overall total is 8048.

Help us improve cfa.nhs.uk

Tell us what's happened so we can fix the problem. Please do not provide any personal, identifiable or sensitive information.

Close

Thanks for the feedback!

Close